Atypical fibroxanthoma and pleomorphic dermal sarcoma

作者: M. Ziemer , I. M. Jäger , E. Dippel

DOI: 10.1007/S00105-019-04471-8

关键词:

摘要: Atypical fibroxanthoma (AFX) or undifferentiated pleomorphic sarcoma (UPS) is a rare malignant neoplastic disease of the skin. At beginning 1960s AFX was described as an independent entity and superficial variant fibrous histiocytoma (MFH). Since then, many controversies on classification have arisen mainly because in cases dedifferentiated neoplasms from other origins were falsely diagnosed AFX. A relevant deep expansion, invasion nerves vessels presence tumor necrosis are being typical for UPS; however, first-line they represent risk factors recurrence. In view clinical histological features it meaningful to consider UPS one disease. recent years studies molecular pathological background attempted make better neoplasm, without able so far name certain specific histopathological characteristic. The AFX/UPS still essence morphological immunohistochemical diagnosis by exclusion.

参考文章(24)
C. Doglioni, C. D. M. Fletcher, A. P. Dei Tos, D. Gasparotto, R. Maestro, L. Laurino, M. Boiocchi, Ultraviolet-induced p53 mutations in atypical fibroxanthoma. American Journal of Pathology. ,vol. 145, pp. 11- 17 ,(1994)
Christopher D.M. Fletcher, Krisjnan Unni, Fredrik Mertens, World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone IARC Press. ,(2002)
Philipp U Heitz, Angela Baer, Bruno Paredes, Daniela Mihic-Probst, Paul Komminoth, Parvin Saremaslani, Jianming Zhao, Christian Oehlschlegel, CGH analysis shows genetic similarities and differences in atypical fibroxanthoma and undifferentiated high grade pleomorphic sarcoma. Anticancer Research. ,vol. 24, pp. 19- 26 ,(2004) , 10.5167/UZH-111580
Richard L. Kempson, Malcolm H. McGavran, Atypical fibroxanthomas of the skin Cancer. ,vol. 17, pp. 1463- 1471 ,(1964) , 10.1002/1097-0142(196411)17:11<1463::AID-CNCR2820171114>3.0.CO;2-E
William A. Kanner, Louis B. Brill, James W. Patterson, Mark R. Wick, CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma. Journal of Cutaneous Pathology. ,vol. 37, pp. 744- 750 ,(2010) , 10.1111/J.1600-0560.2010.01534.X
Aaron H.J. Withers, Nicholas D.L. Brougham, Rachel M. Barber, Swee T. Tan, Atypical fibroxanthoma and malignant fibrous histiocytoma Journal of Plastic Reconstructive and Aesthetic Surgery. ,vol. 64, ,(2011) , 10.1016/J.BJPS.2011.05.004
Akio Sakamoto, Yoshinao Oda, Eijun Itakura, Yumi Oshiro, Sadafumi Tamiya, Yumi Honda, Akira Ishihara, Yukihide Iwamoto, Masazumi Tsuneyoshi, H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma. Human Pathology. ,vol. 32, pp. 1225- 1231 ,(2001) , 10.1053/HUPA.2001.28953
Tricia L. Hultgren, Dominick J. DiMaio, Immunohistochemical staining of CD10 in atypical fibroxanthomas. Journal of Cutaneous Pathology. ,vol. 34, pp. 415- 419 ,(2007) , 10.1111/J.1600-0560.2006.00635.X